Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · IEX Real-Time Price · USD
8.58
+0.49 (6.06%)
At close: Apr 24, 2024, 4:00 PM
8.60
+0.02 (0.23%)
After-hours: Apr 24, 2024, 7:40 PM EDT
Sana Biotechnology Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Sana Biotechnology stock have an average target of 11.67, with a low estimate of 8.00 and a high estimate of 15. The average target predicts an increase of 36.01% from the current stock price of 8.58.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 1, 2024.
Analyst Ratings
The average analyst rating for SANA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $8 → $15 | Buy | Maintains | $8 → $15 | +74.83% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +39.86% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +39.86% | Jan 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | -6.76% | Oct 12, 2023 |
| JMP Securities | JMP Securities | Buy Initiates $9 | Buy | Initiates | $9 | +4.90% | Sep 25, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.23
from -1.46
EPS Next Year
-1.39
from -1.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 73.7M | 381.6M |
| Avg | n/a | n/a | n/a | 30.2M | 151.2M |
| Low | n/a | n/a | n/a | n/a | 14.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,165.3% |
| Avg | - | - | - | - | 401.3% |
| Low | - | - | - | - | -51.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.98 | -0.97 | -0.98 |
| Avg | -1.23 | -1.39 | -1.52 |
| Low | -1.72 | -1.93 | -1.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.